PAX1 / SOX1 DNA Methylation Versus Cytology and HPV16 /18 Genotyping for the Triage of High‐Risk HPV ‐Positive Women in Cervical Cancer Screening: Retrospective Analysis of Archival Samples
BJOG: An International Journal of Obstetrics & Gynaecology · 2025
DOI: 10.1111/1471-0528.17965 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2025. Verfasst von Karen K L Chan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics & Gynaecology, The University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: DNA Methylation, Human papillomavirus 16, Human papillomavirus 18, Paired Box Transcription Factors. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Health and Medical Research Fund.
Abstract (Originalsprache)
Objective
To compare the performance of cytology, HPV16/18 genotyping and PAX1/SOX1 methylation for the triage of high‐risk HPV‐positive cervical samples.
Design
Retrospective analyses of archival samples collected from a large‐scale prospective randomised controlled trial. Setting/Sample HPV‐positive women recruited from the general cervical screening population.
Methods
403 HPV‐positive samples including 113 normal, 173 low‐grade cervical intraepithelial neoplasia (LG‐CIN), 114 HG‐CIN and three cervical cancers. All samples were assessed by liquid‐based cytology, HPV genotyping and PAX1/SOX1 methylation. Main Outcome Measures AUC (area under the curve), sensitivity and specificity for cytology, HPV16/18 genotyping and PAX1/SOX1 methylation for high‐grade (HG) premalignant cervical lesions.
Results
PAX1 was more sensitive than cytology and HPV16/18 genotyping in detecting a HG lesion (CIN2+). The sensitivity for PAX1, SOX1, cytology and HPV16/18 were 73.5% (95% CI: 65.5–81.5), 41.9% (95% CI: 32.9–50.8), 48.7% (95% CI: 39.7–57.8) and 36.8% (95% CI: 28.0–45.5), respectively, and their respective specificities were 70.3% (95% CI: 65.0–75.6), 83.6% (95% CI: 79.3–87.9), 77.6% (95% CI: 72.8–82.5) and 67.1% (95% CI: 61.7–72.6), respectively. Overall, PAX1 gave the best AUC at 0.72. Adding SOX1 to PAX1 did not improve the AUC (0.68). Three hundred and twenty‐two women who did not have a HG lesion at baseline were followed up for two rounds of screening. Fewer women developed a HG lesion with a normal baseline PAX1 compared to women with a normal baseline cytology or negative HPV16/18 (8.4% vs. 14.5% and 17.5%, respectively).
Conclusion
PAX1 triage for referral to colposcopy in HPV‐positive women may be superior to cytology and HPV16/18 genotyping.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics & Gynaecology, The University of Hong Kong, Hong Kong SAR, China.
- Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
ORCID-Profile: Karen K L Chan
Förderung
- Health and Medical Research Fund
Zitieren
APA
Chan, K. K. L., Liu, S. S., Lau, L. S. K., Ngu, S. F., Chu, M. M. Y., Tse, K. Y., Cheung, A. N. Y., & Ngan, H. Y. S. (2025). PAX1 / SOX1 DNA Methylation Versus Cytology and HPV16 /18 Genotyping for the Triage of High‐Risk HPV ‐Positive Women in Cervical Cancer Screening: Retrospective Analysis of Archival Samples. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.17965
Vancouver
Chan KKL, Liu SS, Lau LSK, Ngu SF, Chu MMY, Tse KY, et al. PAX1 / SOX1 DNA Methylation Versus Cytology and HPV16 /18 Genotyping for the Triage of High‐Risk HPV ‐Positive Women in Cervical Cancer Screening: Retrospective Analysis of Archival Samples. BJOG: An International Journal of Obstetrics & Gynaecology. 2025. doi:10.1111/1471-0528.17965
BibTeX
@article{Chan2025,
author = {Chan, Karen K L and Liu, Stephanie S and Lau, Lesley S K and Ngu, Siew Fei and Chu, Mandy M Y and Tse, K Y and Cheung, Annie N Y and Ngan, Hextan Y S},
title = {PAX1 / SOX1 DNA Methylation Versus Cytology and HPV16 /18 Genotyping for the Triage of High‐Risk HPV ‐Positive Women in Cervical Cancer Screening: Retrospective Analysis of Archival Samples},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2025},
doi = {10.1111/1471-0528.17965}
}
EUVIMED